New chemotherapy for colorectal cancer;La nouvelle chimiothérapie des cancers coliques

Presse Medicale

Volumn 31, Issue 3, 2002, Pages 132-138

  Taieb J ^a   Boige, V ^a   Ducreux, Michel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; ORZEL; OXALIPLATIN; RALTITREXED;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FRANCE; HUMAN; LYMPH NODE METASTASIS; POSTOPERATIVE CARE; STANDARD;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; ORGANOPLATINUM COMPOUNDS; POSTOPERATIVE CARE; PRODRUGS; QUINAZOLINES; RANDOMIZED CONTROLLED TRIALS; THIOPHENES; TIME FACTORS;

EID: 0037176569     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial
2. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
3. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
4. Multicentric randomized trial comparing in weekly treatment of adanced colorectal cancer (CRC) intensified 5-fluorouracil and folinic acid (FA) with 5-FU pharmacokinetic monitoring to a constant dose calculaed with body surface area
5. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
6. Multicenter phase III study of 5-fluorouracil (5-FU) or UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer
7. Randomized comparative study of ORZEL (oral uracil/tegafur (UFT) plus leucovorin (LV)) versus parenteral 5-fluorouracil (5-FU) plus LV in patients with metastatic colorectal cancer
8. A phase III trial (SO14796) of Xeloda (Capecitabine) in previously untreated advanced/metastatic colorectal cancer
9. Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
10. Raltitrexed (TomudexR) versus 5-fluorouracil and leucovorin (5-FU + LV) in patients with advanced colorectal cancer (ACC): Results of a randomized multicenter, North American trial
11. Advanced colorectal cancer (ACC): Results from the latest raltitrexed TomudexRcomparative study
12. Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (de Gramont, Lokich and raltitrexed) in metastatic colorectal cancer
13. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
14. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
15. Raltitrexed ('Tomudex') plus oxaliplatin: An active combination for first-line chemotherapy in patients with metastatic colorectal cancer
16. Weekly irinotecan (CPT-11), leucovorin (LV), and fluorouracil (FU) is superior to daily x 5 LV/FU in patients (PTS) with previously untreated metastatic colorectal cancer (CRC)
17. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
18. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
19. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
20. Phase I/II studies: Results in 5-FU refractory colorectal cancer patients
21. FOLFIRI followed by FOLFOX or FOLFOX followed by FOLFIRI in metastatic colorectal cancer: Which is the best sequence? Safety and preliminary efficacy results of a randomized phase III study
22. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial
23. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial
24. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
25. Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer
26. Toxicity report of a phase III trial comparing bimonthly LV5-FU2 to monthly 5-FU-leucovorin high dose in patients with dukes B and C colon cancer
27. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer
28. Comparative efficacy of adjuvant chemotherapy in patients with Dukes'B versus Dukes'C colon cancer: Results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)
29. Monoclonl antibody therapy for resected Dukes'C colorectal cancer: Seven-year outcome of a multicenter randomized trial
30. Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
31. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer